Cardiac Marker Testing Devices Market Continues To Expand As Ortho Clinical Diagnostics Launches New Microtip Partnership Assays For Diabetes, Cardiac, And Rental Testing In Collaboration With Diazyme Laboratories Inc.
Cardiac markers are special antibodies measured in the blood to measure heart function. They can also be used in the detection or early diagnosis of certain diseases. Although they're usually associated with myocardial infarction, they can also be indicative of many other conditions. For instance, hyperthyroidism and thyroid prophylaxis can result in an elevated elevation in plasma marker levels.
Growing burden of cardiovascular
diseases is stimulating the demand for cardiac maker testing devices
significantly. Cardiac markers are biomarkers measured to evaluate heart
function and thus they can be useful in the early prediction of diagnosis of
diseases. According to the American Heart Association (AMA), in 2016,
cardiovascular disease accounted for 17.6 million deaths across the globe.
According to the same source, that number is expected to reach 23.6 million by
2030. Furthermore, according to the World Health Organization (WHO), around
17.9 million people die each year from cardiovascular disease.
Although the relationship between cardiac
disease and cardiac markers is currently not clear, patients with abnormal
cardiac function should be investigated for possible development of these
antibodies. It is possible that these markers can provide early diagnosis and
subsequent treatment options for such diseases, and by detecting them early,
more people can receive optimal care. Furthermore, researchers have identified
a number of potential environmental and dietary factors that may increase the
risk of cardiac disease and can help to identify which lifestyle and dietary
habits may be responsible. High geriatric population is another factor that
researchers have identified, which can accelerate the demand for cardiac maker
testing devices since elderly people are more susceptible to heart-related
diseases.
However, there have been numerous
concerns regarding these devices, primarily the collection and storage of
samples. Some devices have found to be inefficient in collecting the samples
and storing them efficiently. Besides, stringent regulatory compliance policies
are making it difficult for manufacturers to boost their sales. Thus, such
factors can affect negatively the cardiac marker testing devices market
As the technology that supports the
monitoring of heart health continues to advance, it will be easier and more
effective to monitor patients with cardiac disease and monitor their markers.
Medical researchers have been able to develop several different tests to
measure these proteins and are developing new methods to keep up with the
latest developments. The developed regions such as North America and Europe
offer a massive opportunity for medical researchers due to the presence of
robust research facilities and being home to major device manufacturers. Hence,
cardiac marker testing devices have witnessed significant demand in the
above-mentioned regions.
Recently, in July 2018, Ortho
Clinical Diagnostics launched new MicroTip partnership assays for diabetes,
cardiac, and rental testing in collaboration with Diazyme Laboratories Inc.
Comments
Post a Comment